Hsieh Ming 4

What Happened
Ming Hsieh, CEO of Fulgent Genetics (FLGT), had a total of 20,515 shares withheld to satisfy tax-withholding obligations on vested restricted stock units (RSUs). The withheld shares included 2,949 shares at $24.76 on 2026-02-26 (≈ $73,017) and 17,566 shares at $15.33 on 2026-03-01 (≈ $269,287), for a combined value of roughly $342,304. These transactions are coded "F" (shares withheld for tax withholding) — not open-market sales.

Key Details

• Transaction dates and amounts:
  • 2026-02-26: 2,949 shares withheld @ $24.76 = $73,017 (code F)
  • 2026-03-01: 17,566 shares withheld @ $15.33 = $269,287 (code F)
• Total shares withheld: 20,515; total value ≈ $342,304.
• Reason: Tax withholding on RSUs that vested (footnotes):
  • F1: Withholding for RSUs granted Feb 26, 2024 (originally reported 2/28/2024).
  • F2: Withholding for RSUs granted Feb 25, 2025 (originally reported 2/27/2025).
• Additional ownership notes from footnotes:
  • F3–F6 describe securities held in family trusts and UTMA accounts; Hsieh disclaims beneficial interest in the Dynasty Trust (F3) but is trustee of The Ming Hsieh Trust (F4) and custodian for UTMA accounts (F5/F6).
• Shares owned after the withholding are not specified in the excerpt of the filing provided.
• Filing date: Form 4 was filed 2026-03-02; this appears to be timely relative to the transaction dates.

Context
These were routine tax-withholding dispositions tied to RSU vesting (a common corporate practice) rather than voluntary open-market sales; they typically do not indicate the insider's view on the company’s prospects. For retail investors, purchases or open-market sales by insiders often provide clearer signals than tax-withholding transactions.